Ligand validation:4JAN

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4JAN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4JAN_NAG_I_504	28%	71%	0.242	0.894	0.54	0.59	-	-	0	0	100%	0.9333
4JAN_NAG_I_501	23%	64%	0.247	0.868	0.55	0.82	-	1	0	0	100%	0.9333
4JAN_NAG_G_501	17%	65%	0.271	0.853	0.53	0.81	-	1	0	0	100%	0.9333
4JAN_NAG_G_502	12%	69%	0.336	0.863	0.49	0.69	-	-	0	0	100%	0.9333
4JAN_NAG_G_504	9%	63%	0.327	0.825	0.47	0.95	-	1	0	0	100%	0.9333
4JAN_NAG_G_505	9%	68%	0.331	0.826	0.52	0.69	-	-	1	0	100%	0.9333
4JAN_NAG_I_502	7%	67%	0.353	0.803	0.51	0.75	-	-	0	0	100%	0.9333
4JAN_NAG_G_503	5%	50%	0.37	0.774	0.49	1.42	-	3	4	0	100%	0.9333
4JAN_NAG_I_505	1%	67%	0.537	0.769	0.51	0.74	-	-	0	0	100%	0.9333
4JAN_NAG_I_503	1%	68%	0.606	0.704	0.49	0.75	-	-	1	0	100%	0.9333
4LST_NAG_G_501	68%	55%	0.132	0.945	0.46	1.27	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.